About Us
Advertise
Partnership
Submit Press Release
Submit Website
Write for Us
Contact Us
Site Map
Search for:
Search for:
Home
Recent News
Submit Press Release
Submit News Feed
Add News To Your Site
Mac
MacBook Air
MacBook Pro
iMac
Mac mini
Mac Pro
iPod
iPhone
iPad
iTunes
News
Top 25 Songs
Top 25 Albums
Top 25 New Releases
Apps
News
Top 25 Paid Apps
Top 25 Free Apps
TV & Movies
Top Movies
Movie Trailers
Top TV Seasons
Top TV Episodes
Hardware
Software
Aparture
iCloud
iLife
iOS
iWork
Mac OS X
Mac OS X Server
Safari
Newswires
Submit RSS Feed
Video
Submit Content
Submit Press Release
Submit Link
Submit RSS Feed
Home
»
AMEX
»
AMEX TRADED STOCKS
»
ACET ()
Investors NewsDesk and Stock Promotion Service:
AMEX Stocks : ACET () on Investors NewsDesk
Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
Are Investors Undervaluing Adicet Bio, Inc. (NASDAQ:ACET) By 41%?
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Adicet Bio, Inc. Announces Pricing of Public Offering
Adicet Bio, Inc. Announces Proposed Public Offering
Great week for Adicet Bio, Inc. (NASDAQ:ACET) institutional investors after losing 71% over the previous year
Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024
Adicet Bio to Host Conference Call to Provide Updates on its Clinical Pipeline and Corporate Outlook
Adicet Bio Highlights ADI-001 Expansion, Persistence and Pharmacodynamic Profile from Ongoing Phase 1 Study at the 65th American Society of Hematology (ASH) Annual Meeting
Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates
Adicet Bio to Present at the 2023 Jefferies London Healthcare Conference
Adicet Bio Announces Poster Presentation Highlighting ADI-001 Data at the 65th American Society of Hematology (ASH) Annual Meeting
Yahoo! Finance: ACET News
Facebook
Linked In
Buzz
Rss
Twitter
Mashable
View More NewsWires
Submit RSS Feed
Submit Website
View More Websites